Dietary isoflavones act on bone marrow osteoprogenitor cells and stimulate ovary development before influencing bone mass in pre-pubertal piglets.
Food containing soybeans provide isoflavone phytoestrogens that can preserve bone mass in postmenopausal women, and prevent bone loss in ovariectomized rats. But their effects on bone remain unclear, particularly on bone formation during growth. Two groups of eight pre-pubertal piglets were fed a basal or an isoflavone-enriched (S800) diet for 6 weeks. The S800 diet contained 800 mg SoyLifetrade mark/kg, providing 2.8 mg isoflavones/kg body weight/day. Several bones were collected and tested for bone strength and density. Bone marrow was collected from humeri together with blood samples and genital tracts. The plasma concentrations of isoflavones were increased in the pigs fed S800, but growth rate, body weight, plasma bone markers, bone mineral density, and strength were all unaffected. In contrast, cultured stromal cells from S800 pigs had more alkaline phosphatase-rich cells and mineralized nodules, secreted more osteocalcin, osteoprotegerin and RANK-L, synthesized more osteoprotegerin, and RANK-L. Cultured mononucleated nonadherent bone marrow cells from S800 pigs developed fewer tartrate-resistant acid phosphatase mononucleated cells (osteoclast progenitors) when cultured with 1,25(OH)(2)D(3), and resorbed a smaller area of dentine slices. Freshly isolated bone marrow osteoclast progenitors from S800 pigs had more caspase-3 cleavage activity, and synthesized less RANK. Both osteoclast and osteoblast progenitors had ERalpha and ERbeta, whose syntheses were stimulated by the S800 diet. The S800 piglets had heavier ovaries with more follicles, but their uterus weight was unaffected. We conclude that dietary isoflavones have no detectable effect on the bone mass of growing female piglets, but act on bone marrow osteoprogenitors via ERs--mainly ERbeta, and stimulate ovary development.
De Wilde
Anne
A
NuReLice, INRA, Jouy-en-Josas, France.
Maria Rassi
Claudia
C
Cournot
Giulia
G
Colin
Colette
C
Lacroix
Herminie C
HC
Chaumaz
Gilles
G
Coxam
Veronique
V
Bennetau-Pelissero
Catherine
C
Pointillart
Alain
A
Lieberherr
Michele
M
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D001854:Bone Marrow Cells / Q000187:drug effects*; D004032:Diet; D005260:Female; D007529:Isoflavones / Q000008:administration & dosage / Q000494:pharmacology*; D010006:Osteoblasts / Q000378:metabolism; D015675:Osteocalcin / Q000378:metabolism; D010010:Osteoclasts / Q000378:metabolism; D010053:Ovary / Q000187:drug effects* / Q000254:growth & development; D053245:RANK Ligand / Q000378:metabolism; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D012741:Sexual Maturation / Q000502:physiology*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D013552:Swine / Q000502:physiology*
D007529:Isoflavones; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D011960:Receptors, Estrogen; D015675:Osteocalcin; D000469:Alkaline Phosphatase